Trust Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Trust Asset Management's BMY Position: Q2 2026 in Review
Trust Asset Management increased its Bristol-Myers Squibb (BMY) stake by 0.39% in Q2 2026, buying an estimated $5.05K and bringing the position to 22,705 shares worth $1.31M. The position accounts for 0.08% of the portfolio, ranked #79.
Trust Asset Management first reported a position in BMY in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.76M in Q2 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Trust Asset Management held 22,705 shares of Bristol-Myers Squibb worth $1.31M as of Q2 2026.
- Trust Asset Management bought 88 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.05K.
- Bristol-Myers Squibb made up 0.08% of Trust Asset Management's portfolio in Q2 2026, its #79 holding.
- Trust Asset Management first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 25 quarters since.
- Trust Asset Management's Bristol-Myers Squibb position peaked at $1.76M in Q2 2022.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.